Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia

A Benigni, P Boccardo, M Galbusera… - American journal of …, 1993 - Elsevier
Patients with chronic renal failure may experience a bleeding tendency and blood loss after
surgical procedures or trauma. Altered platelet function has been indicated as the major …

Abnormal cytoskeletal assembly in platelets from uremic patients.

G Escolar, M Diaz-Ricart, A Cases… - The American journal …, 1993 - ncbi.nlm.nih.gov
The mechanisms involved in the hemostatic abnormality of uremic patients remain obscure.
We have explored the response of normal and uremic platelets to surface activation at the …

Flow-cytometric analysis of mepacrine-labelled platelets in patients with end-stage renal failure

MP Gawaz, C Bogner, HJ Gurland - Pathophysiology of Haemostasis …, 1993 - karger.com
Platelet dysfunction and increased bleeding tendency has been the most consistently
described haemostatic abnormality in patients with renal failure. Besides abnormalities in …

Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients

G Castaman, F Rodeghiero, A Lattuada… - American journal of …, 1993 - Wiley Online Library
Several studies have reported increased von Willebrand factor (vWF) levels in plasma of
uremic patients, with a normal multimeric pattern. Two recent studies, however, have shown …

Platelet Adhesivity to Subendothelium Is Influenced by Polymorphonuclear Leukocytes: Studies with Spirin and Salicylate

R Hernández, M Alemany, J Bozzo, MR Buchanan… - Haemostasis, 1993 - karger.com
Interactions between blood platelets and polymorphonuclear leukocytes (PMN) influence
cell reactivity. We have examined the effects of inhibiting platelet and PMN cyclooxygenase …

Possible involvement of serotonin in the haemostatic action of DDAVP in patients with uraemia

J Malyszko, J Malyszko, M Pietraszek… - … in Bleeding Disorders, 1993 - Springer
The effect of DDAVP on some haemostatic and fibrinolytic parameters as well as on plasma
and platelet serotonin was studied. DDAVP was administered intravenously in a dose of 0.4 …